These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21387320

  • 1. Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs).
    Kern A, Görgens H, Dittert DD, Krüger S, Richter KK, Schackert HK, Saeger HD, Baretton G, Pistorius S.
    J Surg Oncol; 2011 Jul 01; 104(1):59-65. PubMed ID: 21387320
    [Abstract] [Full Text] [Related]

  • 2. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.
    Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Dei Tos AP.
    Am J Surg Pathol; 2010 Oct 01; 34(10):1480-91. PubMed ID: 20861712
    [Abstract] [Full Text] [Related]

  • 3. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.
    J Surg Oncol; 2008 Sep 01; 98(3):175-8. PubMed ID: 18618605
    [Abstract] [Full Text] [Related]

  • 4. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G.
    Diagn Mol Pathol; 2011 Mar 01; 20(1):22-33. PubMed ID: 21326036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
    Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 01; 11(4):371-5. PubMed ID: 18636362
    [Abstract] [Full Text] [Related]

  • 11. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
    Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G.
    J Clin Pathol; 2005 Jun 01; 58(6):634-9. PubMed ID: 15917417
    [Abstract] [Full Text] [Related]

  • 12. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.
    Cancer; 2008 Feb 01; 112(3):608-15. PubMed ID: 18076015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
    Koelz M, Lense J, Wrba F, Scheffler M, Dienes HP, Odenthal M.
    Int J Oncol; 2011 Feb 01; 38(2):503-11. PubMed ID: 21132270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
    Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.
    Am J Surg Pathol; 2007 Feb 01; 31(2):224-32. PubMed ID: 17255767
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.